A Pilot Study of COVID-19 Outcomes in People Living with HIV in Tatarstan
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010288 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Natalya Andreeva und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, 420008 Kazan, Russia. Hauptthemen laut MEDLINE: COVID-19, HIV Infections. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kazan Federal University Strategic Academic Leadership Program, Ministry of Higher Education, Science, and Innovation of the Republic of Uzbekistan.
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID-19) pandemic remains a significant public health threat globally with significant socio-economic impacts. People living with human immunodeficiency virus (HIV) (PLWH) have a high risk of severe outcomes of COVID-19 due to immunosuppression. Clinical manifestation of COVID-19 in HIV patients largely remains unclear. We carried out a pilot study to investigate the clinical laboratory data and circulating cytokines in PLWH infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in Tatarstan, Russia. Serum samples were collected from three groups: PLWH with COVID-19 (PLWH/COVID-19), COVID-19-only, and uninfected controls. We found an increased risk of severe COVID-19 in PLWH/COVID-19 patients compared to COVID-19-only. Four fatal cases were in PLWH/COVID-19, while there was no fatality in COVID-19-only. Pro-inflammatory cytokines, such as IL-5, IL-6, IL-9, and IL-15, were elevated in PLWH/COVID-19 compered to COVID-19-only. These preliminary findings highlight the potential for more severe COVID-19 in PLWH/COVID-19 where pro-inflammatory cytokines could play pathogenic role.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, 420008 Kazan, Russia.
- Department of Infectious Diseases, Kazan State Medical Academy, 420012 Kazan, Russia.
- Department of Medical Biology and Genetics, Kazan State Medical University, 420012 Kazan, Russia.
- Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Lynnwood Road, Hatfield, Pretoria 0002, South Africa.
- Center for Advanced Technologies, Tashkent 100174, Uzbekistan.
ORCID-Profile: Natalya Andreeva, Svetlana Moiseeva, Ilnur Salafutdinov, Yuriy Davidyuk, Sinothile Khuzwayo, Mirakbar Yakubov, Albert Rizvanov, Ilsiyar Khaertynova, Emmanuel Kabwe
Förderung
- Kazan Federal University Strategic Academic Leadership Program
- Ministry of Higher Education, Science, and Innovation of the Republic of Uzbekistan
Zitieren
APA
Andreeva, N., Moiseeva, S., Garipova, A., Shakirova, V., Martynova, E., Salafutdinov, I., Khaiboullina, S., Davidyuk, Y., Khuzwayo, S., Gama, N., Turdikulova, S., Dalimova, D., Yakubov, M., Morzunov, S., Rizvanov, A., Khaertynova, I., & Kabwe, E. (2025). A Pilot Study of COVID-19 Outcomes in People Living with HIV in Tatarstan. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010288
Vancouver
Andreeva N, Moiseeva S, Garipova A, Shakirova V, Martynova E, Salafutdinov I, et al. A Pilot Study of COVID-19 Outcomes in People Living with HIV in Tatarstan. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010288
BibTeX
@article{Andreeva2025,
author = {Andreeva, Natalya and Moiseeva, Svetlana and Garipova, Alisa and Shakirova, Venera and Martynova, Ekaterina and Salafutdinov, Ilnur and Khaiboullina, Svetlana and Davidyuk, Yuriy and Khuzwayo, Sinothile and Gama, Ntombenhle and Turdikulova, Shahlo and Dalimova, Dilbar and Yakubov, Mirakbar and Morzunov, Sergey and Rizvanov, Albert and Khaertynova, Ilsiyar and Kabwe, Emmanuel},
title = {A Pilot Study of COVID-19 Outcomes in People Living with HIV in Tatarstan},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010288}
}
EUVIMED